On the other hand, there is evidence that LPS infusion mediates the development of obesity, increasing the amount of adipose tissue and glucose intolerance via activation of TLR4 in adipocytes.35 This evidence suggests that changes in LPS levels could be associated with changes in fat mass and VO2 consumption. The gene discussed is TLR4; the disease is Glucose intolerance.